Alzheimer's disease and Helicobacter pylori infection: Defective immune regulation and apoptosis as proposed common links

Medical Hypotheses

Volumn 68, Issue 2, 2007, Pages 378-388

  Kountouras, Jannis ^a   Gavalas, Emmanuel ^a   Zavos, Christos ^a   Stergiopoulos, Christos ^a   Chatzopoulos, Dimitrios ^a   Kapetanakis, Nikolaos ^a   Gisakis, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HOMOCYSTEINE; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL INFECTION; CELLULAR IMMUNITY; DEGENERATIVE DISEASE; ENDOTHELIUM LESION; HELICOBACTER PYLORI; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; LEUKOCYTE AGGREGATION; MOLECULAR MIMICRY; NERVE DEGENERATION; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; TISSUE INJURY; VASCULAR DISEASE;

ALZHEIMER DISEASE; ANTIBODIES, BACTERIAL; APOPTOSIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G;

HELICOBACTER PYLORI;

EID: 33845301977     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.06.052     Document Type: Article

References (134)

1. Tuppo E.E., and Arias H.R. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 37 (2005) 289-305
2. Small G.W., Rabins P.V., Barry P.P., et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278 (1997) 1363-1371
3. Itzhaki R.F., Wozniak M.A., Appelt D.M., and Balin B.J. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 25 (2004) 619-627
4. Pulido R., Jimenez-Escrig A., Orensanz L., Saura-Calixto F., and Jimenez-Escrig A. Study of plasma antioxidant status in Alzheimer's disease. Eur J Neurol 12 (2005) 531-535
5. Ankarcrona M., and Winblad B. Biomarkers for apoptosis in Alzheimer's disease. Int J Geriatr Psychiatry 20 (2005) 101-105
6. Gelinas D.S., DaSilva K., Fenili D., St George-Hyslop P., and McLaurin J. Immunotherapy for Alzheimer's disease. Proc Natl Acad Sci USA 101 Suppl. 2 (2004) 14657-14662
7. Blasko I., and Grubeck-Loebenstein B. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging 20 (2003) 101-113
8. Aisen P.S. The development of anti-amyloid therapy for Alzheimer's disease: from secretase modulators to polymerisation inhibitors. CNS Drugs 19 (2005) 989-996
9. Tian X., Cecal R., McLaurin J., et al. Identification and structural characterisation of carboxy-terminal polypeptides and antibody epitopes of Alzheimer's amyloid precursor protein using high-resolution mass spectrometry. Eur J Mass Spectrom (Chichester, Eng) 11 (2005) 547-556
10. Buttini M., Masliah E., Barbour R., et al. Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J Neurosci 25 (2005) 9096-9101
11. Town T., Nikolic V., and Tan J. The microglial "activation" continuum: from innate to adaptive responses. J Neuroinflamm 2 (2005) 24
12. Malm T.M., Koistinaho M., Parepalo M., et al. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18 (2005) 134-142
13. Rogers J., and Lue L.F. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int 39 (2001) 333-340
14. Hashioka S., Monji A., Ueda T., Kanba S., and Nakanishi H. Amyloid-beta fibril formation is not necessarily required for microglial activation by the peptides. Neurochem Int 47 (2005) 369-376
15. Singh V.K. Immune-activation model in Alzheimer disease. Mol Chem Neuropathol 28 (1996) 105-111
16. Mrak R.E., and Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26 (2005) 349-354
17. Singh V.K. Neuroautoimmunity: pathogenic implications for Alzheimer's disease. Gerontology 43 (1997) 79-94
18. Aarli J.A. Role of cytokines in neurological disorders. Curr Med Chem 10 (2003) 1931-1937
19. Iribarren P., Cui Y.H., Le Y., and Wang J.M. The role of dendritic cells in neurodegenerative diseases. Arch Immunol Ther Exp (Warsz) 50 (2002) 187-196
20. Minagar A., Shapshak P., Fujimura R., Ownby R., Heyes M., and Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202 (2002) 13-23
21. Akiyama H., Barger S., Barnum S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
22. Nelson P.T., Soma L.A., and Lavi E. Microglia in diseases of the central nervous system. Ann Med 34 (2002) 491-500
23. Gordon M.N. Microglia and immune activation in Alzheimer's disease. J Fla Med Assoc 80 (1993) 267-270
24. Ulvestad E., Williams K., Bjerkvig R., Tiekotter K., Antel J., and Matre R. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol 56 (1994) 732-740
25. McGeer P.L., Itagaki S., Tago H., and McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79 (1987) 195-200
26. Williams Jr. K., Ulvestad E., Cragg L., Blain M., and Antel J.P. Induction of primary T cell responses by human glial cells. J Neurosci Res 36 (1993) 382-390
27. Takuma K., Yan S.S., Stern D.M., and Yamada K. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. J Pharmacol Sci 97 (2005) 312-316
28. LeBlanc A.C. The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res 2 (2005) 389-402
29. Chong Z.Z., Li F., and Maiese K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev 49 (2005) 1-21
30. Huang Y., Erdmann N., Peng H., Zhao Y., and Zheng J. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol 2 (2005) 113-122
31. Giuliani F., Hader W., and Yong V.W. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol 78 (2005) 135-143
32. Lee E.O., Shin Y.J., and Chong Y.H. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor. J Neuroimmunol 155 (2004) 21-31
33. Zhao M., Cribbs D.H., Anderson A.J., et al. The induction of the TNF alpha death domain signaling pathway in Alzheimer's disease brain. Neurochem Res 28 (2003) 307-318
34. Su J.H., Anderson A.J., Cribbs D.H., et al. Fas and Fas ligand are associated with neuritic degeneration in the Alzheimer's disease brain and participate in beta-amyloid-induced neuronal death. Neurobiol Dis 12 (2003) 182-193
35. Lombardi V.R., Fernandez-Novoa L., Etcheverria I., Seoane S., and Cacabelos R. Association between APOE epsilon4 allele and increased expression of CD95 on T cells from patients with Alzheimer's disease. Methods Find Exp Clin Pharmacol 26 (2004) 523-529
36. Ethell D.W., and Buhler L.A. Fas ligand-mediated apoptosis in degenerative disorders of the brain. J Clin Immunol 23 (2003) 439-446
37. Morishima Y., Gotoh Y., Zieg J., et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 21 (2001) 7551-7560
38. Yao M., Nguyen T.V., and Pike C.J. Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci 25 (2005) 1149-1158
39. Marx F., Blasko I., and Grubeck-Loebenstein B. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint. Arch Immunol Ther Exp (Warsz) 47 (1999) 205-209
40. Monsonego A., and Weiner H.L. Immunotherapeutic approaches to Alzheimer's disease. Science 302 (2003) 834-838
41. Tatton W.G., Chalmers-Redman R.M., Ju W.Y., Wadia J., and Tatton N.A. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J Neural Transm Suppl 49 (1997) 245-268
42. Siao C.J., and Tsirka S.E. Extracellular proteases and neuronal cell death. Extracellular proteases and neuronal cell death. Cell Mol Biol (Noisy-le-grand) 48 (2002) 151-161
43. Bayer A.U., Keller O.N., Ferrari F., and Maag K.P. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 133 (2002) 135-137
44. McKinnon S.J. Glaucoma: ocular Alzheimer's disease?. Front Biosci 8 (2003) S1140-S1156
45. Kountouras J., Zavos C., and Chatzopoulos D. Induction of apoptosis as a proposed pathophysiological link between glaucoma and Helicobacter pylori infection. Med Hypotheses 62 (2004) 378-381
46. Okuda Y., Apatoff B.R., and Posnett D.N. Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis. J Neuroimmunol 171 (2006) 163-170
47. D'Andrea M.R. Add Alzheimer's disease to the list of autoimmune diseases. Med Hypotheses 64 (2005) 458-463
48. Singh V.K. Studies of neuroimmune markers in Alzheimer's disease. Mol Neurobiol 9 (1994) 73-81
49. Fernandez-Shaw C., Marina A., Cazorla P., Valdivieso F., and Vazquez J. Anti-brain spectrin immunoreactivity in Alzheimer's disease: degradation of spectrin in an animal model of cholinergic degeneration. J Neuroimmunol 77 (1997) 91-98
50. Bouras C., Riederer B.M., Kovari E., Hof P.R., and Giannakopoulos P. Humoral immunity in brain aging and Alzheimer's disease. Brain Res Brain Res Rev 48 (2005) 477-487
51. Kountouras J., Deretzi G., Zavos C., et al. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 12 (2005) 139-143
52. Wax M.B., Tezel G., Saito I., et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 125 (1998) 145-157
53. Maruyama I., Nakazawa M., and Ohguro H. Autoimmune mechanisms in molecular pathology of glaucomatous optic neuropathy. Nippon Ganka Gakkai Zasshi 105 (2001) 205-212
54. Kinoshita J. Pathogens as a cause of Alzheimer's disease. Neurobiol Aging 25 (2004) 639-640
55. Robinson S.R., Dobson C., and Lyons J. Challenges and directions for the pathogen hypothesis of Alzheimer's disease. Neurobiol Aging 25 (2004) 629-637
56. Marshall B.J., and Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1 (1984) 1311-1315
57. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 272 (1994) 65-69
58. Blaser M.J. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161 (1990) 626-633
59. Mendall M.A., Goggin P.M., Molineaux N., et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71 (1994) 437-439
60. McColl K.E. What remaining questions regarding Helicobacter pylori and associated diseases should be addressed by future research? View from Europe. Gastroenterology 113 (1997) S158-S162
61. Kountouras J., Mylopoulos N., Chatzopoulos D., et al. Eradication of Helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma. Arch Intern Med 162 (2002) 1237-1244
62. Xu Q., Schett G., Perschinka H., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102 (2000) 14-20
63. Sawayama Y., Ariyama I., Hamada M., et al. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT). Atherosclerosis 178 (2005) 303-309
64. De la Torre J.C., and Stefano G.B. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev 34 (2000) 119-136
65. Hofman A., Ott A., Breteler M.M., et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349 (1997) 151-154
66. Mecocci P., Parnetti L., Reboldi G.P., et al. Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias. Acta Neurol Scand 84 (1991) 210-213
67. Wardlaw J.M., Sandercock P.A., Dennis M.S., and Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 34 (2003) 806-812
68. Pasquier F., and Leys D. Why are stroke patients prone to develop dementia?. J Neurol 244 (1997) 135-142
69. Kranzer K., Sollner L., Aigner M., et al. Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells. Infect Immun 73 (2005) 4180-4189
70. Enarsson K., Brisslert M., Backert S., and Quiding-Jarbrink M. Helicobacter pylori induces transendothelial migration of activated memory T cells. Infect Immun 73 (2005) 761-769
71. D'Elios M.M., Amedei A., Benagiano M., Azzurri A., and Del Prete G. Helicobacter pylori, T cells and cytokines: the "dangerous liaisons". FEMS Immunol Med Microbiol 44 (2005) 113-119
72. Hafsi N., Voland P., Schwendy S., et al. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 173 (2004) 1249-1257
73. Suzuki T., Kato K., Ohara S., et al. Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa. Pathol Int 52 (2002) 265-271
74. Rathinavelu S., Kao J.Y., Zavros Y., and Merchant J.L. Helicobacter pylori outer membrane protein 18 (Hp1125) induces dendritic cell maturation and function. Helicobacter 10 (2005) 424-432
75. Voland P., Hafsi N., Zeitner M., Laforsch S., Wagner H., and Prinz C. Antigenic properties of HpaA and Omp18, two outer membrane proteins of Helicobacter pylori. Infect Immun 71 (2003) 3837-3843
76. Archimandritis A., Sougioultzis S., Foukas P.G., Tzivras M., Davaris P., and Moutsopoulos H.M. Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis; influence of H. pylori eradication. Clin Exp Immunol 119 (2000) 464-467
77. Krauss-Etschmann S., Gruber R., Plikat K., et al. Increase of antigen-presenting cells in the gastric mucosa of Helicobacter pylori-infected children. Helicobacter 10 (2005) 214-222
78. D'Elios M.M., Amedei A., Azzurri A., et al. Molecular specificity and functional properties of autoreactive T-cell response in human gastric autoimmunity. Int Rev Immunol 24 (2005) 111-122
79. Jones N.L., Day A.S., Jennings H., Shannon P.T., Galindo-Mata E., and Sherman P.M. Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling. Infect Immun 70 (2002) 2591-2597
80. Hasumi K., Tanaka K., Saitoh S., et al. Roles of tumor necrosis factor-alpha-receptor type 1 and Fas in the Helicobacter pylori-induced apoptosis of gastric epithelial cells. J Gastroenterol Hepatol 17 (2002) 651-658
81. Wu Y.Y., Tsai H.F., Lin W.C., et al. Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells. World J Gastroenterol 10 (2004) 2334-2339
82. Neu B., Puschmann A.J., Mayerhofer A., et al. TNF-alpha induces apoptosis of parietal cells. Biochem Pharmacol 65 (2003) 1755-1760
83. Watanabe S., Takagi A., Koga Y., Kamiya S., and Miwa T. Helicobacter pylori induces apoptosis in gastric epithelial cells through inducible nitric oxide. J Gastroenterol Hepatol 15 (2000) 168-174
84. Potthoff A., Ledig S., Martin J., et al. Significance of the caspase family in Helicobacter pylori induced gastric epithelial apoptosis. Helicobacter 7 (2002) 367-377
85. Maeda S., Yoshida H., Mitsuno Y., et al. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut 50 (2002) 771-778
86. Chang C.S., Chen W.N., Lin H.H., Wu C.C., and Wang C.J. Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma. World J Gastroenterol 10 (2004) 2232-2240
87. Liu H.F., Liu W.W., Wang G.A., and Teng X.C. Effect of Helicobacter pylori infection on Bax protein expression in patients with gastric precancerous lesions. World J Gastroenterol 11 (2005) 5899-5901
88. Yamasaki E., Wada A., Kumatori A., et al. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic protein Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J Biol Chem 281 (2006) 11250-11259
89. Fernandez-Vizarra P., Fernandez A.P., Castro-Blanco S., et al. Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol Dis 15 (2004) 287-305
90. Tezel G., and Wax M.B. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J Neurosci 20 (2000) 3552-3562
91. Vorobjova T., Faller G., Maaroos H.I., et al. Significant increase in antigastric autoantibodies in a long-term follow-up study of H. pylori gastritis. Virchows Arch 437 (2000) 37-45
92. Negrini R., Savio A., Poiesi C., et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111 (1996) 655-665
93. Basso D., Gallo N., Zambon C.F., et al. Antigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammation. Int J Clin Lab Res 30 (2000) 173-178
94. Sheu B.S., Shiesh S.C., Yang H.B., Su I.J., Chen C.Y., and Lin X.Z. Implications of Helicobacter pylori serological titer for the histological severity of antral gastritis. Endoscopy 29 (1997) 27-30
95. Moran A.P., and Prendergast M.M. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun 16 (2001) 241-256
96. Chiba S., Sugiyama T., Matsumoto H., et al. Antibodies against Helicobacter pylori were detected in the cerebrospinal fluid obtained from patients with Guillain-Barre syndrome. Ann Neurol 44 (1998) 686-688
97. Chiba S., Sugiyama T., Yonekura K., et al. An antibody to VacA of Helicobacter pylori in cerebrospinal fluid from patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 73 (2002) 76-78
98. Kountouras J., Zavos C., and Chatzopoulos D. Apoptosis and autoimmunity as proposed pathogenetic links between Helicobacter pylori infection and idiopathic achalasia. Med Hypotheses 63 (2004) 624-629
99. Kountouras J., Mylopoulos N., Konstas A.G., Zavos C., Chatzopoulos D., and Boukla A. Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 241 (2003) 884-890
100. Malaguarnera M., Bella R., Alagona G., Ferri R., Carnemolla A., and Pennisi G. Helicobacter pylori and Alzheimer's disease: a possible link. Eur J Intern Med 15 (2004) 381-386
101. Kountouras J., Tsolaki M., Gavalas E., et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66 (2006) 938-940
102. Fennerty M.B. Helicobacter pylori. Arch Intern Med 154 (1994) 721-727
103. Weinstein W.M. Gastritis and gastropathies. In: Sleisenger M.H., and Fordtran J.S. (Eds). Gastrointestinal disease: pathology, diagnosis, management. 5th ed. (1993), Saunders, Philadelphia 545-571
104. Peterson W.L., and Graham D.Y. Helicobacter pylori. In: Feldman M., Friedman L.S., and Sleisenger M.H. (Eds). Sleisenger & Fordtran's gastrointestinal & liver disease. 7th ed. (2002), Saunders, Philadelphia 732-746
105. Santarelli L., Gabrielli M., Cremonini F., et al. Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther 19 (2004) 107-111
106. White A.R., Huang X., Jobling M.F., et al. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem 76 (2001) 1509-1520
107. Nilsson K., Gustafson L., and Hultberg B. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population. Clin Chem 46 (2000) 691-696
108. Bertram L., and Tanzi R.E. The genetic epidemiology of neurodegenerative disease. J Clin Invest 115 (2005) 1449-1457
109. Panes J., and Granger D.N. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114 (1998) 1066-1090
110. Sevush S., Jy W., Horstman L.L., Mao W.W., Kolodny L., and Ahn Y.S. Platelet activation in Alzheimer disease. Arch Neurol 55 (1998) 530-536
111. Hasitz M., Racz Z., Nagy A., and Lipcsey A. Importance of platelet functions in Alzheimer's disease. Arch Gerontol Geriatr 21 (1995) 53-61
112. Halliday G., Robinson S.R., Shepherd C., and Kril J. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 27 (2000) 1-8
113. Kountouras J., Zavos C., and Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med 9 (2005) 196-207
114. Cacquevel M., Lebeurrier N., Cheenne S., and Vivien D. Cytokines in neuroinflammation and Alzheimer's disease. Curr Drug Targets 5 (2004) 529-534
115. Finch C.E. Developmental origins of aging in brain and blood vessels: an overview. Neurobiol Aging 26 (2005) 281-291
116. Hallam D.M., Capps N.L., Travelstead A.L., Brewer G.J., and Maroun L.E. Evidence for an interferon-related inflammatory reaction in the trisomy 16 mouse brain leading to caspase-1-mediated neuronal apoptosis. J Neuroimmunol 110 (2000) 66-75
117. Ma S.L., Tang N.L., Lam L.C., and Chiu H.F. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol Aging 26 (2005) 1005-1010
118. Sugaya K., Uz T., Kumar V., and Manev H. New anti-inflammatory treatment strategy in Alzheimer's disease. Jpn J Pharmacol 82 (2000) 85-94
119. Xia M., Qin S., McNamara M., Mackay C., and Hyman B.T. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 150 (1997) 1267-1274
120. Singh V.K., and Guthikonda P. Circulating cytokines in Alzheimer's disease. J Psychiatr Res 31 (1997) 657-660
121. Miragliotta G., Del P.R., and Mosca A. Helicobacter pylori infection and coronary heart disease. Lancet 344 (1994) 751
122. Gotz J.M., Thio J.L., Verspaget H.W., et al. Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut 40 (1997) 591-596
123. Kawamoto E.M., Munhoz C.D., Glezer I., et al. Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease. Neurobiol Aging 26 (2005) 857-864
124. Aliyev A., Chen S.G., Seyidova D., et al. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci 229-230 (2005) 285-292
125. Kountouras J., Chatzopoulos D., and Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology 48 (2001) 743-751
126. Beal M.F. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. J Bioenerg Biomembr 36 (2004) 381-386
127. Kountouras J., Zavos C., and Chatzopoulos D. Primary open-angle glaucoma: pathophysiology and treatment. Lancet 364 (2004) 1311-1312
128. Akimoto M., Hashimoto H., Shigemoto M., and Yokoyama I. Relationship between recurrence of gastric ulcer and the microcirculation. J Cardiovasc Pharmacol 31 Suppl 1 (1998) S507-S508
129. Slomiany B.L., Piotrowski J., and Slomiany A. Up-regulation of endothelin-converting enzyme-1 in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun 267 (2000) 801-805
130. Minami M., Kimura M., Iwamoto N., and Arai H. Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 509-513
131. Zhang W.W., Badonic T., Hoog A., et al. Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1. J Neurol Sci 122 (1994) 90-96
132. Panchal M., Rholam M., and Brakch N. Abnormalities of peptide metabolism in Alzheimer disease. Curr Neurovasc Res 1 (2004) 317-323
133. Tezel G., Kass M.A., Kolker A.E., Becker B., and Wax M.B. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma 6 (1997) 83-89
134. Shin Y.J., and Chong Y.H. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor. J Neuroimmunol 155 (2004) 21-31